Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-030918
Filing Date
2024-10-09
Accepted
2024-10-09 07:46:52
Documents
1
Period of Report
2024-10-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3926
  Complete submission text file 0001437749-24-030918.txt   5712
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Issuer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address AEGERION PHARMACEUTICALS, INC. 101 MAIN STREET, SUITE 1850 CAMBRIDGE MA 02142
Business Address
Fraser Craig (Reporting) CIK: 0001557420 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39290 | Film No.: 241361512